Co-Diagnostics (CODX) Tops Q3 EPS by 1c

Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $641.14 thousand versus the consensus estimate of $375 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Crude Inventory Fell 1.7 Million Barrels Last Week - EIA
• Sinclair backs FCC review of national broadcast ownership cap
• Increasing unusual option volume: MAT FHN BNY CNP SKE CCCC TBCH COTY DLO IONS